David Johnson

2019 - Global Blood Therapeutics

In 2019, David Johnson earned a total compensation of $3.2M as Chief Commercial Officer at Global Blood Therapeutics, a 27% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$250,000
Option Awards$1,267,784
Salary$453,125
Stock Awards$1,211,000
Other$5,000
Total$3,186,909

Johnson received $1.3M in option awards, accounting for 40% of the total pay in 2019.

Johnson also received $250K in non-equity incentive plan, $453.1K in salary, $1.2M in stock awards and $5K in other compensation.

Rankings

In 2019, David Johnson's compensation ranked 3,830th out of 13,971 executives tracked by ExecPay. In other words, Johnson earned more than 72.6% of executives.

ClassificationRankingPercentile
All
3,830
out of 13,971
73rd
Division
Manufacturing
1,384
out of 5,701
76th
Major group
Chemicals And Allied Products
486
out of 2,200
78th
Industry group
Drugs
410
out of 1,886
78th
Industry
Pharmaceutical Preparations
311
out of 1,398
78th
Source: SEC filing on April 28, 2021.

Johnson's colleagues

We found four more compensation records of executives who worked with David Johnson at Global Blood Therapeutics in 2019.

2019

Ted Love

Global Blood Therapeutics

Chief Executive Officer

2019

Jeffrey Farrow

Global Blood Therapeutics

Chief Financial Officer

2019

Jung Choi

Global Blood Therapeutics

Chief Business and Strategy Officer

2019

Tricia Suvari

Global Blood Therapeutics

Chief Legal Officer

News

You may also like